PeriVision
Company

Last deal

Amount

Seed

Stage

01.05.2023

Date

4

all rounds

$3.4M

Total amount

General

About Company
PeriVision is developing next-generation systems for testing visual function and improving the diagnosis and monitoring of eye diseases.

Industry

Sector :

Subsector :

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

With a disease-centric approach, PeriVision focuses on addressing the unmet need for more efficient and effective monitoring of glaucoma, a chronic eye condition that can lead to blindness. By using artificial intelligence and virtual reality technology, PeriVision provides patient-friendly, faster, and cost-efficient visual field testing, enabling early detection and continuous monitoring of glaucoma to prevent preventable blindness.